Whittier Trust Co Of Nevada Lowered Citigroup Com New (C) Stake By $507,408; Mimedx Group (MDXG) Shorts Raised By 5.63%

October 12, 2017 - By Migdalia James

Whittier Trust Co Of Nevada Inc decreased Citigroup Inc Com New (C) stake by 10.32% reported in 2017Q2 SEC filing. Whittier Trust Co Of Nevada Inc sold 7,688 shares as Citigroup Inc Com New (C)’s stock rose 1.55%. The Whittier Trust Co Of Nevada Inc holds 66,779 shares with $4.47M value, down from 74,467 last quarter. Citigroup Inc Com New now has $201.53B valuation. The stock declined 1.56% or $1.17 reaching $73.77 per share. About 11.25M shares traded. Citigroup Inc (NYSE:C) has risen 35.60% since October 12, 2016 and is uptrending. It has outperformed by 18.90% the S&P500.

Mimedx Group Incorporated (NASDAQ:MDXG) had an increase of 5.63% in short interest. MDXG’s SI was 23.33M shares in October as released by FINRA. Its up 5.63% from 22.09 million shares previously. With 2.04M avg volume, 11 days are for Mimedx Group Incorporated (NASDAQ:MDXG)’s short sellers to cover MDXG’s short positions. The SI to Mimedx Group Incorporated’s float is 23.85%. About 302,929 shares traded. MiMedx Group Inc (NASDAQ:MDXG) has risen 107.87% since October 12, 2016 and is uptrending. It has outperformed by 91.17% the S&P500.

Since May 25, 2017, it had 0 insider buys, and 2 insider sales for $1.53 million activity. Taylor William Charles sold $1.16M worth of stock.

MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The company has market cap of $1.41 billion. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. It has a 68.06 P/E ratio. The Company’s biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix.

Among 8 analysts covering MiMedx Group (NASDAQ:MDXG), 6 have Buy rating, 2 Sell and 0 Hold. Therefore 75% are positive. MiMedx Group had 19 analyst reports since July 29, 2015 according to SRatingsIntel. Northland Capital upgraded the stock to “Outperform” rating in Friday, October 30 report. The firm has “Buy” rating by Needham given on Tuesday, October 10. The stock has “Buy” rating by Canaccord Genuity on Friday, December 18. Needham maintained MiMedx Group Inc (NASDAQ:MDXG) on Thursday, July 27 with “Buy” rating. As per Thursday, July 13, the company rating was maintained by Piper Jaffray. Aegis Capital initiated the shares of MDXG in report on Tuesday, November 8 with “Buy” rating. The stock has “Strong Buy” rating by Needham on Monday, November 16. The stock has “Underweight” rating by First Analysis on Tuesday, May 23. Needham maintained it with “Buy” rating and $2000 target in Friday, July 14 report. The company was downgraded on Wednesday, July 29 by Needham.

Investors sentiment increased to 2.02 in Q2 2017. Its up 0.59, from 1.43 in 2017Q1. It increased, as 16 investors sold MiMedx Group Inc shares while 41 reduced holdings. 48 funds opened positions while 67 raised stakes. 66.99 million shares or 10.63% more from 60.55 million shares in 2017Q1 were reported. Washington Trust Comml Bank reported 7,000 shares or 0.02% of all its holdings. Raymond James Fincl Ser Advsrs Incorporated holds 55,100 shares or 0.01% of its portfolio. 172,955 are owned by Citigroup Incorporated. First Bancshares stated it has 0.1% in MiMedx Group Inc (NASDAQ:MDXG). Murphy Mngmt reported 0.05% in MiMedx Group Inc (NASDAQ:MDXG). Sg Americas Secs Limited Liability reported 33,643 shares. Thompson Investment Mgmt has 341,650 shares for 0.96% of their portfolio. 3.26 million were accumulated by Macquarie Group Limited. Patten And Patten Tn invested 0.05% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG). Jpmorgan Chase & stated it has 62,677 shares or 0% of all its holdings. Sei Investments, Pennsylvania-based fund reported 515 shares. 7,153 were accumulated by Clarivest Asset Mngmt Limited Company. Dupont Capital Mgmt Corp invested 0.05% in MiMedx Group Inc (NASDAQ:MDXG). Capstone Asset Co has 47,450 shares. Rowland And Invest Counsel Adv has 0% invested in MiMedx Group Inc (NASDAQ:MDXG).

Whittier Trust Co Of Nevada Inc increased Vanguard Interm Corp (VCIT) stake by 5,575 shares to 28,621 valued at $2.51M in 2017Q2. It also upped Ishares Tr Core Msci Eafe (IEFA) stake by 18,577 shares and now owns 156,064 shares. Ishares National 0 (SUB) was raised too.

Among 36 analysts covering Citigroup Inc. (NYSE:C), 18 have Buy rating, 3 Sell and 15 Hold. Therefore 50% are positive. Citigroup Inc. had 94 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Macquarie Research given on Friday, November 18. The firm has “Buy” rating given on Monday, September 21 by Evercore. The stock of Citigroup Inc (NYSE:C) has “Hold” rating given on Tuesday, January 26 by Deutsche Bank. The firm earned “Hold” rating on Monday, August 24 by Vetr. The firm has “Overweight” rating given on Thursday, April 7 by JP Morgan. The firm earned “Buy” rating on Monday, October 9 by Credit Suisse. The firm earned “Perform” rating on Tuesday, January 5 by Oppenheimer. The rating was upgraded by Atlantic Securities to “Overweight” on Wednesday, December 21. The firm earned “Hold” rating on Tuesday, June 6 by Jefferies. The stock of Citigroup Inc (NYSE:C) has “Buy” rating given on Monday, September 25 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com